Basics Sana Biotechnology, Inc. IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $942.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 4.26% Avg Daily Range (30 D): $0.15 | 4.71% Avg Daily Range (90 D): $0.13 | 5.54% Institutional Daily Volume Avg Daily Volume: 1.61M Avg Daily Volume (30 D): 5.1M Avg Daily Volume (90 D): 3.98M Trade Size Avg Trade Size (Sh.): 131 Avg Trade Size (Sh.) (30 D): 220 Avg Trade Size (Sh.) (90 D): 241 Institutional Trades Total Inst.Trades: 1,239 Avg Inst. Trade: $1.91M Avg Inst. Trade (30 D): $1.37M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.06M Avg Closing Trade (30 D): $1.51M Avg Closing Trade (90 D): $1.44M Avg Closing Volume: 259.49K     News Jul 15, 2025 @ 8:00 AM Draig Therapeutics Appoints Experienced Biotech Le... Source: Mark Swallow, Sandi Greenwood May 19, 2025 @ 2:22 PM SANA Investors Have Opportunity to Lead Sana Biote... Source: Prnewswire May 14, 2025 @ 6:50 PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LL... Source: Faruqi & Faruqi, Llp May 12, 2025 @ 1:50 PM SANA Investors Have Opportunity to Lead Sana Biote... Source: Prnewswire May 11, 2025 @ 1:40 PM Faruqi & Faruqi Reminds Sana Biotechnology Investo... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.88 $-.21 $-.21 Diluted EPS $-.88 $-.21 $-.21 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -208.67M $ -49.39M $ -49.07M Operating Income / Loss $ -212.63M $ -50.63M $ -50.87M Cost of Revenue $ $ $ Net Cash Flow $ -80.56M $ -31.07M $ .57M PE Ratio